Na II - Search Results

1

Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck.

Ahn HJ, Na II, Park YH, Cho SY, Lee BC, Lee GH, Koh JS, Lee YS, Shim YS, Kim YK, Kang HJ, Ryoo BY, Yang SH. Ahn HJ, et al. Among authors: na ii. Oral Oncol. 2010 Aug;46(8):607-11. doi: 10.1016/j.oraloncology.2010.05.005. Epub 2010 Jul 8. Oral Oncol. 2010. PMID: 20615750

2

Presence of malignant mesothelial cells in the sputum.

Choi YH, Park KY, Ryoo BY, Na II, Yang SH, Koh JS, Kim CH, Lee JC. Choi YH, et al. Among authors: na ii. Intern Med. 2008;47(1):57-60. doi: 10.2169/internalmedicine.47.0348. Epub 2008 Jan 1. Intern Med. 2008. PMID: 18176007 Free article.

3

Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha.

Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH, Kim CH, Yoo YD, Lee JC. Rho JK, et al. Among authors: na ii. Oncol Rep. 2009 Mar;21(3):801-7. Oncol Rep. 2009. PMID: 19212642

4

Prognostic factor analysis and proposed prognostic model for conventional treatment of high-grade primary gastric lymphoma.

Park YH, Kim WS, Bang SM, Lee SI, Uhm JE, Kang HJ, Na II, Yang SH, Lee SS, Kim K, Jung CW, Park K, Ko YH, Ryoo BY. Park YH, et al. Among authors: na ii. Eur J Haematol. 2006 Oct;77(4):304-8. doi: 10.1111/j.1600-0609.2006.00709.x. Epub 2006 Jul 27. Eur J Haematol. 2006. PMID: 16879609

5

Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia.

Na II, Kang HJ, Park YH, Lee SS, Yoo HJ, Choe DH, Ryoo BY, Yang SH. Na II, et al. Eur J Haematol. 2007 Jul;79(1):1-7. doi: 10.1111/j.1600-0609.2007.00876.x. Eur J Haematol. 2007. PMID: 17598834

6

Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer.

Kim SY, Kim HR, Kim CH, Koh JS, Baek HJ, Choi CM, Song JS, Lee JC, Na II. Kim SY, et al. Among authors: na ii. Ann Thorac Med. 2017 Jan-Mar;12(1):36-41. doi: 10.4103/1817-1737.197774. Ann Thorac Med. 2017. PMID: 28197220 Free PMC article.

7

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.

Lim SM, Kim SW, Cho BC, Kang JH, Ahn MJ, Kim DW, Kim YC, Lee JS, Lee JS, Lee SY, Park KU, An HJ, Cho EK, Jang TW, Kim BS, Kim JH, Lee SS, Na II, Yoo SS, Lee KH. Lim SM, et al. Among authors: na ii. Cancer Res Treat. 2020 Oct;52(4):1112-1119. doi: 10.4143/crt.2020.245. Epub 2020 May 15. Cancer Res Treat. 2020. PMID: 32599984 Free PMC article.

8

Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Lee JY, Na II, Jang SH, Hwang YI, Choe du H, Kim CH, Baek H. Lee JY, et al. Among authors: na ii. J Thorac Dis. 2013 Dec;5(6):758-63. doi: 10.3978/j.issn.2072-1439.2013.11.24. J Thorac Dis. 2013. PMID: 24409352 Free PMC article.

9

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer.

Hwang JP, Lim I, Na II, Cho EH, Kim BI, Choi CW, Lim SM. Hwang JP, et al. Among authors: na ii. Nucl Med Mol Imaging. 2014 Jun;48(2):114-20. doi: 10.1007/s13139-013-0255-z. Epub 2013 Dec 6. Nucl Med Mol Imaging. 2014. PMID: 24900151 Free PMC article.

10

Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children.

Kim J, Lee BS, Kim B, Na I, Lee J, Lee JY, Park MR, Kim H, Sohn I, Ahn K. Kim J, et al. Benef Microbes. 2017 Oct 13;8(5):755-761. doi: 10.3920/BM2017.0034. Benef Microbes. 2017. PMID: 29035111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters